Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results

Sigilon Therapeutics, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/15/2023 4 Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Unknown transaction of 683,760 shares @ $14.92, valued at $10.2M
Unknown transaction of 113,960 shares @ $14.92, valued at $1.7M
08/14/2023 4 ELI LILLY & Co (10% Owner) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Bought 1,718,493 shares @ $14.92, valued at $25.6M
08/11/2023 4 Cole Douglas G. (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Disposed/sold 683 options to buy @ $6.6439, valued at $4.5k
Disposed/sold 683 options to buy @ $4.9984, valued at $3.4k
08/11/2023 4 Oesterle Stephen N. (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Disposed/sold 683 options to buy @ $6.6439, valued at $4.5k
Disposed/sold 683 options to buy @ $4.9984, valued at $3.4k
Disposed/sold 4,273 options to buy @ $7.51, valued at $32.1k
08/11/2023 4 Shaff Eric D. (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Disposed/sold 683 options to buy @ $6.6439, valued at $4.5k
Disposed/sold 683 options to buy @ $4.9984, valued at $3.4k
08/11/2023 4 RUFFOLO ROBERT R (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Disposed/sold 683 options to buy @ $6.6439, valued at $4.5k
Disposed/sold 683 options to buy @ $4.9984, valued at $3.4k
Disposed/sold 3,754 options to buy @ $7.51, valued at $28.2k
08/11/2023 4 Cox John (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Disposed/sold 341 shares @ $0
Disposed/sold 683 options to buy @ $6.6439, valued at $4.5k
Disposed/sold 683 options to buy @ $4.9984, valued at $3.4k
08/11/2023 4 Kowalsky Matthew Paul (CHIEF OF STAFF AND CLO) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Disposed/sold 1,925 shares @ $0
Disposed/sold 12,690 options to buy @ $0.75, valued at $9.5k
08/11/2023 4 Patel Kavita (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Disposed/sold 683 options to buy @ $6.6439, valued at $4.5k
Disposed/sold 683 options to buy @ $4.9984, valued at $3.4k
08/11/2023 4 Ashton-Rickardt Philip (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Disposed/sold 8,845 options to buy @ $0.75, valued at $6.6k
08/11/2023 4 Yuan Qing Sarah (CTOO) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Disposed/sold 2,884 shares @ $0
Disposed/sold 8,846 options to buy @ $0.75, valued at $6.6k
08/11/2023 4 Vivaldi Coelho Rogerio (PRESIDENT AND CEO) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Disposed/sold 12,169 shares @ $0
Disposed/sold 35,382 options to buy @ $0.75, valued at $26.5k
08/11/2023 4 Pontes Josias (CFO) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Disposed/sold 3,504 shares @ $0
Disposed/sold 10,767 options to buy @ $0.75, valued at $8.1k
07/27/2023 4 Yuan Qing Sarah (CTOO) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Exercised 2,884 options to buy @ $19.24, valued at $55.5k
07/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/07/2023 3 ELI LILLY & Co (10% Owner) has filed a Form 3 on Sigilon Therapeutics, Inc.
03/01/2023 4 Kowalsky Matthew Paul (CHIEF OF STAFF AND CLO) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Granted 165,000 options to buy @ $1.09, valued at $179.9k
03/01/2023 4 Vivaldi Coelho Rogerio (PRESIDENT AND CEO) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Granted 460,000 options to buy @ $1.09, valued at $501.4k
03/01/2023 4 Pontes Josias (CFO) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Granted 140,000 options to buy @ $1.09, valued at $152.6k
03/01/2023 4 Ashton-Rickardt Philip (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Granted 115,000 options to buy @ $1.09, valued at $125.4k
03/01/2023 4 Yuan Qing Sarah (CTOO) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Granted 115,000 options to buy @ $1.09, valued at $125.4k
03/01/2023 3 Kowalsky Matthew Paul (CHIEF OF STAFF AND CLO) has filed a Form 3 on Sigilon Therapeutics, Inc.
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Story Brooke (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Granted 8,888 options to buy @ $0.7632, valued at $6.8k
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/04/2022 4 Yuan Qing Sarah (CTOO) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Granted 120,000 options to buy @ $1.48, valued at $177.6k
03/10/2022 3 Yuan Qing Sarah (CTOO) has filed a Form 3 on Sigilon Therapeutics, Inc.
02/22/2022 4 Ashton-Rickardt Philip (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Granted 90,000 options to buy @ $1.48, valued at $133.2k
02/22/2022 4 Pontes Josias (ACTING CHIEF FINANCIAL OFFICE) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Granted 60,000 options to buy @ $1.48, valued at $88.8k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy